To verify our hypothesis, we applied 4-OI to activate Nrf2 and observed the effect of 4-OI (200 μM) combined with oxaliplatin(30 μM) or lobaplatin(16 μg/ml) on CRC cells. Here, NFE2L2 is linked to colorectal carcinoma.